This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm.
Journal of diabetes science and technology, 8(5), 1011-7
Citation
Renukuntla, Venkat Sasidhar; Ramchandani, Neesha; Trast, Jeniece; Cantwell, Martin; Heptulla, Rubina A. (2014). Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm.. Journal of diabetes science and technology, 8(5), 1011-7. https://doi.org/10.1177/1932296814542153